Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACE2 Chewing Gum for SARS-CoV-2 Viral Load
NCT05433181Phase 2Withdrawn
- Sponsor
- University of Pennsylvania
- Start
- Feb 2025
- Primary completion
- Apr 2025
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of CTB-ACE2 in coronavirus disease 2019 (COVID-19), sponsored by University of Pennsylvania. Planned start Feb 2025; status: withdrawn.
02
Drugs
CTB-ACE2
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05433181.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05433181.